Max Healthcare Institute Limited (MAXHEALTH.NS) fair value

ACCE thesis

Max Healthcare runs a network of multi-specialty private hospitals across northern and western India, with its flagship facilities in Delhi NCR, Mohali and Mumbai, and it earns most of its revenue from inpatient care, cardiac, oncology and transplant procedures. The case rests on scarcity and pricing power: quality tertiary beds in India's wealthiest urban catchments are hard to build and slow to staff, and that lets an operator with strong clinical brands sustain a 62.5% gross margin and a 19.7% operating margin. Revenue growth of 16.7% is the number to test, because it has to come from rising occupancy, higher-acuity case mix and new beds rather than from price alone. The stock trades at 54.8 times trailing earnings and 35.0 times forward earnings, so the market is already paying for that growth, and the gap between the two multiples shows how much earnings expansion analysts are pencilling in. The question for a deeper look is whether bed additions and ramp-up of recent hospitals keep margins near current levels as the company scales, since a sustained slide in operating margin would make the premium multiple harder to justify.